baber/WOPTO huggingface dataset:
Patent IL-108189-A0 (IL)
Title: 4-Hydroxy-2'-nitrobutyrophenone and tetrahydro-2-(0-nitrophenyl)-2-furanol useful as intermediates in the preparation of a crop selective herbicide
IPC: C07D307/20
Filed: 1993-12-27
Abstract: The following are claimed: A) 4-hydroxy-2'-nitrobutyrophenone (I); B) tetrahydro-2-(o-nitrophenyl)-2-furanol (II): and C) prepn. of 4-halo-2'-nitrobutyrophenone of formula (III) comprising reacting a cpd. of formula (IV) with a 2-haloethanol cpd. of formula (V) in the presence of an aq. base and a phase transfer catalyst, opt. in the presence of an organic solvent to form (I) and/or (II), and further reacting (I) and/or (II) with a hydrogen halide to form (III). X' = halo; R = 1-4C alkyl X" = Cl or Br. The hydrogen halide is used as an excess amt. and is HCl or HBr. The solvent is water and/or an aromatic hydrocarbon such as toluene. The reaction temp. is 40-130 deg.C. One molar equiv. of the 2-haloethanol cpd. is used. The phase transfer catalyst is benzyltrimethylammonium hydroxide and the aq. base is NaOH. (I) and/or (II) can be prepd. by reacting dihydro-3-(o-nitrobenzoyl)-2(3H)-furanone with an aq. acid selected from sulphuric acid, phosphoric acid and acetic acid, opt. in the presence of an organic solvent.
Patent IL-110164-A0 (IL)
Title: Quinazoline derivatives
IPC: C07D403/04
Filed: 1994-06-29
Abstract: The invention concerns quinazoline derivatives of the formula I <CHEM> wherein R<1> includes hydroxy, amino, hydroxyamino, (1-4C)alkoxy, (1-4C)alkylamino and di-[(1-4C)alkyl]amino;  R<3> is halogeno; n is 1, 2 or 3 and R<2> includes hydrogen, hydroxy, halogeno and (1-4C)alkyl;  or a pharmaceutically-acceptable salt thereof; processes for their preparation; pharmaceutical compositions containing them; and the use of the receptor tyrosine kinase inhibitory properties of the compounds in the treatment of cancer.
Patent IL-112178-A0 (IL)
Title: Expression plasmid having unique insertion site
IPC: C12R1/19
Filed: 1994-12-29
Abstract: Disclosed is an improved plasmid which upon introduction into a suitable Escherichia coli host cell containing the thermolabile repressor CI, renders the host cell capable, upon increasing the temperature of the host cell to a temerature at which the repressor is destroyed, of effecting expression of a gene encoding superoxide dismutase inserted into the vector, and production of the superoxide dismutase encoded by the gene.
Patent IL-126673-A0 (IL)
Title: Radio controlled engine kill switch
IPC: B60R25/04
Filed: 1997-04-24
Abstract: A engine kill switch system has a transmitter and receiver which are linked through specific transmitted codes within a frequency. The receiver is mounted directly on the boat and wired to an engine kill switch, maintaining the switch in the closed position as long as a signal is received from all of the activated transmitters. Once the transmitter signal is unintentionally deactivated, the receiver shuts down the engine. A range adjustment allows the separation distance between the transmitter and receiver to be changed, dependent upon the size of the boat and end use. A strobe and audio warning can also be attached to the receiver and activated simultaneously with, or as an alternative to, the deactivation of the engine. Automatic transmitter activation and deactivation can be provided through storage ports tied to the receiver. The transmitter is a battery powered remote device carried by a user. The transmitter has a programmed unique code recognized by the receiver. The system, or individual components, are provided with deactivation codes entered through an input device. The system can also be used as an antitheft device simply by removal of one transmitter, thereby rendering the engine inoperable.
Patent IL-128044-A0 (IL)
Title: Analogues of camptothecin their preparation and pharmaceutical compositions containing them
IPC: C07D491/04
Filed: 1999-01-14
Abstract: Camptothecin analogues where the camptothecin hydroxy lactone is: (i) a  beta -hydroxy lactone; or (ii) the corresp.  beta -hydroxy acid resulting from ring-opening of the aforementioned lactone; or a (iii) deriv. of the  beta -hydroxy acid in (ii) or its one of its salts. Also claimed are new industrial prods. of formula (M) and (A). R1 = lower alkyl, lower alkenyl, lower alkynyl, halo(lower alkyl), lower alkoxy(lower alkyl) or lower alkylthio(lower alkyl); R20 = H or halo; R22 = F, Cl, or lower alkoxy; R23 = prim. hydroxy-protecting gp.; and R18, R19 = H, halo, lower alkyl, lower alkoxy or OH.
Patent IL-128212-A0 (IL)
Title: Detection of small molecules by use of a piezo electric sensor
IPC: G01N33/543
Filed: 1999-01-25
Abstract: A protein comprising an antigen-binding portion formed by two cooperating peptide sequences of FIGS. 3 A and 3 B of the application. The protein may alternatively comprise an altered antigen-binding portion where at least one of the peptide sequences is an altered sequence, an altered sequence being a sequence of FIG. 3 A or 3 B in which one or more of an amino acid residue has been added, deleted or replaced by another amino acid residue. The altered antigen-binding portion retains substantially the same antigen-binding specificity as said antigen-binding portion. Also disclosed are apparatus, systems and methods for detecting small assayed molecules in a sample using the protein.
Patent IL-129434-A0 (IL)
Title: Method of transmission and device to carry out said method
IPC: H04L27/10
Filed: 1997-11-03
Abstract: The method involves modulating a signal input to a transmitter or write unit for transmission to a receiver or reader unit. The transmitter generates angle modulated pulses with successive opposed angular modulations during a pulse period superimposed to form a folding pulse on which information is superimposed by modulation or encoding. The received folding pulses is filtered in two or more dispersion filters connected in parallel pairs with frequency dependent group transmission time characteristics matched to the angular modulation of the pulses. The filters output a pair of combined signals consisting of a time compressed signal with increased amplitude and an extended signal with reduced amplitude which are fed to a second superimposition element. -
Patent IL-143117-A0 (IL)
Title: System for controlling in vivo camera frame capture and frame display rates
IPC: A61B1/05
Filed: 2001-05-13
Abstract: An in vivo camera system is described, which comprises: an in-vivo capsule comprising an imager; a storage device for storing frames captured by the imager; an image processor for calculating a frame capture rate from at least two of the frames; and a controller for providing a calculated frame capture rate to the capsule.
Patent IL-146818-A0 (IL)
Title: New formulation
IPC: A61K9/00
Filed: 2000-06-20
Abstract: An oral dosage form comprising a core material coated with a semipermeable membrane wherein the core material comprises an active ingredient selected from the group of omeprazole, an alkaline salt thereof, <i>S</i>-omeprazole and an alkaline salt thereof, in admixture with one or more alkaline additives, one or more swelling agents, and optionally pharmaceutically acceptable excipients, and the dosage form is not enteric coated.
Patent IL-150067-A0 (IL)
Title: Stabilizing peptides, polypeptides and antibodies which include them
IPC: A61P37/00
Filed: 2000-12-29
Abstract: Object of the present invention are peptides which stabilize antibodies including them even in a reducing medium, in particular cytoplasmic medium, the polypeptides which include at least one of the above mentioned peptides, antibodies which include these polypeptides, and polynucleotides coding for peptides, polypeptides and antibodies of the invention. <IMAGE>
Patent IL-150333-A0 (IL)
Title: Electronic alarm timer for use with a medical regimen
IPC: G04F3/00
Filed: 2001-02-19
Abstract: A timer for assisting in the control of various medical regimen is described. The timer is particularly adapted for use in avoiding or assuring conception by providing a graphic representation on the timer to alert a user as to when a medically correct step needs to be taken. The timer is provided with an alarm that alerts one as to when a transition from one particular part of, for example, a contraceptive regimen to another part of the regimen is about to occur and illustrates the transition on the graphic representation. A status of the regimen is also presented to a user. One graphic representation involves an hour-glass filled with granules corresponding in number to the amount of time left before a transition in the medical regimen is to occur.
Patent IL-154974-A0 (IL)
Title: Inhibition of the growth factor dependency of tumor cells
IPC: A61K45/00
Filed: 2001-10-17
Abstract: The invention relates to the use of progesterone receptor inhibitors for inhibition of growth-factor-dependency of tumor cells.
Patent IL-156881-A0 (IL)
Title: Syringe and method for the use thereof
IPC: A61M5/178
Filed: 2001-05-10
Abstract: A syringe and its method of use, comprising two bodies; the first body or cylinder provided with a support surface at its end, and a second body or rod with pusher elements, which is introduced in the prior cylinder. The syringe can be used by means of a single hand and it is possible to perform the two actions of a syringe, sucking and injection, by changing the position of the fingers. <IMAGE>
Patent IL-164545-A0 (IL)
Title: Water resistant ink jet recordable substrate
IPC: G11B5/70
Filed: 2004-10-13
Abstract: The present invention is directed to an ink jet recordable substrate. In particular, the present invention relates to a water-resistant coating composition for an ink jet recordable substrate, a method for preparing the coating composition and a method of applying said coating composition to produce a water-resistant ink jet recordable substrate. The water-resistant coating composition includes an aqueous polyurethane dispersion; an aqueous solution of a cationic nitrogen-containing polymeric dye fixative compound; and an acrylic polymer, wherein the coating composition has a pH of 7 or less.
Patent IL-165157-A0 (IL)
Title: Electrical connector including thermoplastic elastomer material and associated methods
IPC: H01R3/00
Filed: 2004-11-10
Abstract: An electrical connector may include a connector body having a passageway therethrough with a first end for receiving therein an electrical bushing insert, and a second end for receiving therein an electrical conductor. The connector body may have an outer end portion adjacent the first end of the passageway being movable between an unseated position and a seated position, and the connector body may also include indicia on an outer end portion that has a visibility changing to indicate the seated position. The indicia may take the form of a colored band. The outer end portion may move to the flared shape upon abutting the shoulder of the electrical bushing insert. When properly seated, the indicia will be visible to the technician looking down along the axis of the electrical bushing insert and first connector end.
Patent IL-165552-A0 (IL)
Title: An apparatus and method for beating and rolling a food dough belt
IPC: A21C3/02
Filed: 2004-12-05
Abstract: Conventionally, wrinkles may arise on the surface of a bread dough belt, depending on the properties of the bread dough, mechanical conditions, etc., and the gluten structure in the bread dough belt may be harmed, when the bread dough belt is stretched or rolled while air bubbles are kept in the surface layer.  To overcome these problems, this invention provides a method for beating and rolling a fermented dough belt (50) to release the fermentation-gas in the dough belt, comprising beating and rolling the dough belt (50) being conveyed on a conveying and rolling roller (20) by a plurality of rolling rollers (11) sequentially moving upstream from downstream on the dough belt (50).
Patent IL-176763-A0 (IL)
Title: Process for purification of proteins expressed in bacteria
IPC: C12N15/19
Filed: 2006-07-10
Abstract: This patent application relates to a process for the purification of proteins expressed in prokaryotic cells, which comprises interposing a reverse phase chromatography step between the extraction/denaturation and the renaturation steps.
Patent IL-197406-A0 (IL)
Title: Use of ranolazine for the preparation of a medicament for the treatment of arrhythmias
IPC: A61P9/06
Filed: 2009-03-05
Abstract: Methods are provided for treating arrhythmias including tachycardias, such as idiopathic ventricular tachycardia, ventricular fibrillation, and Torsade de Pointes (TdP) in a manner that minimizes undesirable side effects.
Patent IL-207672-A0 (IL)
Title: Method for the synthesis of a bifunctional complex
IPC: C12N15/10
Filed: 2010-08-18
Abstract: Disclosed is a method for obtaining a bifunctional complex comprising a display molecule part and a coding part wherein a nascent bifunctional complex comprising a chemical reaction site and priming site for enzymatic addition of a tag is reacted at the chemical reaction site with one or more reactants, and provided with respective tag(s) identifying the reactant(s) at the priming site using one or more enzymes.
Patent IE-20000297-A1 (IE)
Title: Imidazolyl-alkenoic Acids
Inventor: WEINSTOCK JOSEPH
IPC: C07D233/70
Filed: 1990-06-13
Abstract: Angiotensin II receptor antagonists having the formula: [FORMULA I] which are useful in regulating hypertension and in the treatment of congestive heart failure, renal failure, and glaucoma, pharmaceutical compositions including these antagonists, and methods of using these compounds to product angiotensin II receptor antagonism in mammals.
Patent IE-910982-A1 (IE)
Title: Selective adenosine receptor agents
IPC: A61P9/12
Filed: 1991-03-25
Abstract: Xanthine derivatives which act selectively at adenosine receptors and which act in general as adenosine antagonists are disclosed. From in vitro studies it is known that specific physiological effects can be distinguished as a result of this selectivity and that adenosine receptor activity in vitro correlates with adenosine receptor activity in vivo. Pharmaceutical preparations of the subject compounds can be prepared on the basis of the selective binding activity of the compounds disclosed herein which will enhance certain physiological effects while minimizing others, such as decreasing blood pressure without decreasing heart rate.
Patent LU-86684-A1 (LU)
Title: Chalk eraser for blackboard - comprises sponge rollers rotating at different speeds with assigned internal brushes removing chalk
Inventor: CHEN JIN-SHENG
IPC: B43L/
Filed: 1986-11-21
Abstract: The eraser has a top plate (20) of plastics material, a base plate (30), three sponge-covered rollers (10,11,12) and three internal brushes (51,52,53). Near the ends of the rollers - mounted on the roller shafts - are spur gears. The spur gears on the outer rollers have more teeth than those (111,112) on the centre roller (11). The gears are linked by idler gears (41,42), so that when the eraser is rubbed across the board, the centre roller rotates at greater speed than the outer ones. Directly below each roller is a brush (51,52,53) which removes the chalk dust from the sponge surfaces as the rollers rotate. The whole assembly is clipped together and secured by end caps.
Patent LU-87693-A1 (LU)
Inventor: MAILLIET PIERRE
IPC: C21C5/46
Filed: 1990-03-07
Abstract: The probe comprises a support in the form of a sheath, a series of internal pipes, retained by spacers and connecting orifices distributed along the sheath to a device for measuring and for receiving the gas samples outside the furnace, and thermocouples arranged at the level of the said orifices. In order to enable the pipes to be replaced without disassembly of the probe, the said orifices are situated in steps provided in the sheath, while the internal pipes, for taking gas samples and heat measurements are all individual, straight and exchangeable elements housed in straight support and protection channels, each traversing the sheath from the outside as far as the respective step.
Patent MA-22492-A1 (MA)
Inventor: INMAN E JR
IPC: C11D1/82
Filed: 1992-04-03
Abstract: Disclosed are hair conditioning shampoo compositions, containing a detersive surfactant component, a silicone hair conditioning agent, and water and preferably comprising a suspending agent for the silicone conditioning agent. The detersive surfactant component comprises, at least in part, polyethylene glycol glyceryl fatty ester nonionic surfactant. The compositions hereof provide improved silicone deposition.
Patent MA-26883-A1 (MA)
Inventor: GYURIK ROBERT
IPC: A61K9/70
Filed: 2002-09-11
Abstract: A composition comprising a pharmaceutical compound, a membrane-permeation enhancer, and a polymeric film-forming agent, including, for example, a hydrocarbon-based liquid nail lacquer comprising a solution of an anti-fungal agent in a pharmaceutically-effective amount, a membrane-compatible permeation enhancer in an amount effective to enhance penetration through a membrane or nail of said anti-fungal agent, a polymeric film-forming agent in an amount effective to form an adherent polymeric film on a membrane or nail, and a solvent for forming said solution; and a method for forming on a membrane or nail of the body an adherent film containing a pharmaceutical compound and permeation enhancer from a solution of the components in which there is used a mixture of solvents, including a solvent which is highly volatile and a solvent of lower volatility.
Patent MA-27863-A1 (MA)
Title: Forme posologique à libération prolongée d'anesthésiques pour le traitement de la douleur
Inventor: CHEN GUOHUA
IPC: A61K9/22
Filed: 2005-12-23
Abstract: Forme posologique à libération prolongée d'anesthésiques pour le traitement de la douleur L'invention concerne des formes posologiques à libération prolongée et des kits comprenant un anesthésique qui peut être appliqué à un endroit souhaité. La présente invention concerne également les procédés de préparation et d'administration des formes posologiques.
Patent MA-28017-A1 (MA)
Inventor: CHEN MENG HSIN
IPC: C07D401/12
Filed: 2006-03-01
Abstract: This invention relates to potent potassium channel blocker compounds of Formula (I) or a formulation thereof for the treatment of glaucoma and other conditions which leads to elevated intraoccular pressure in the eye of a patient. This invention also relates to the use of such compounds to provide a neuroprotective effect to the eye of mammalian species, particularly humans, or a pharmaceutically acceptable salt, in vivo hydrolysable ester, enantiomer, diastereomer or mixture thereof: formula (II) represents C<SUB>6-10 </SUB>aryl or C<SUB>3-10 </SUB>heterocyclyl, said aryl or heterocyclyl optionally substituted with 1-3 groups selected from R<SUP>a</SUP>; Z represents (CH<SUB>2</SUB>)<SUB>n</SUB>PO(OR)(OR*).
Patent MA-38867-A1 (MA)
Title: Antagonistes de v1a pour traiter des troubles du sommeil impliquant un décalage de phase
Inventor: SCHNIDER PATRICK
IPC: A61P25/00
Filed: 2016-02-23
Abstract: La présente invention concerne une nouvelle utilisation médicale de certains composés chimiques et des compositions pharmaceutiques contenant ceux-ci. L'invention concerne des composés qui sont des antagonistes sélectifs de v1a à utiliser dans le traitement de troubles du sommeil impliquant un décalage de phase, en particulier dans le traitement du décalage horaire. Selon un autre aspect, l'invention concerne une composition pharmaceutique à utiliser dans le traitement de troubles du sommeil impliquant un décalage de phase, comprenant un composé selon l'invention et un véhicule pharmaceutiquement acceptable.
Patent MA-39057-A1 (MA)
Title: Composition de liant pour mortiers, betons et enduits legers a agregats vegetaux ou bio-sources
Inventor: PETER ULRIKE
IPC: C04B28/10
Filed: 2016-05-25
Abstract: Composition de liant pour mortiers, bétons et enduits légers à agrégats végétaux ou bio-sourcés, plus particulièrement pour béton de chanvre, comprenant un premier composant minéral conventionnel et de la chaux éteinte pulvérulente, ladite composition de liant étant caractérisée en ce qu'elle présente une surface spécifique calculée selon la méthode bet supérieure à 10 m2/g, de préférence supérieure à 12 m2/g, en particulier supérieure à 14 m2/g et en ce que ladite chaux éteinte pulvérulente est présente en une quantité strictement supérieure à 20 % en poids, en particulier égale ou supérieure à 25% en poids, de préférence égale ou supérieure à 30 % en poids, avantageusement égale ou supérieure à 40% en poids et égale ou inférieure à 80 % en poids, en particulier égale ou inférieure à 60 % en poids, par rapport au poids total de ladite composition de liant.
Patent MA-39325-A1 (MA)
Title: Système de climatisation utilisant l’énergie thermique solaire
Inventor: BOUYA MOHSINE
IPC: F25B29/00
Filed: 2016-09-05
Abstract: Un système de climatisation qui utilise les effets combinés de la compression électrique et un apport thermique solaire pour générer un cycle de froid. L'énergie thermique est capturée à partir du rayonnement solaire grâce à des tubes sous vide. Ceci réduit les besoins énergétiques du compresseur et évite les pics de consommations en période de canicule. Cette climatisation utilise également un échange thermique pour générer de l'air chaud à partir du rayonnement solaire.
Patent MA-39437-A1 (MA)
Title: Compositions comprenant un virus adéno-associé exprimant des constructions à double anticorps et leurs utilisations
Inventor: WILSON JAMES
IPC: C12N15/861
Filed: 2016-11-04
Abstract: La présente invention concerne un virus adéno-associé recombiné (aav) comprenant un capside d'aav et un acide nucléique hétérologue inclus dans celui-ci qui exprime deux constructions d'anticorps fonctionnels dans une cellule. L'invention concerne également des anticorps comprenant une chaîne lourde et une chaîne légère d'un anticorps hétérologue. Dans un mode de réalisation, les anticorps sont co-exprimés à partir d'un vecteur contenant : une première cassette d'expression qui code pour au moins un premier cadre ouvert de lecture (orf) pour une première immunoglobuline sous le contrôle de séquences régulatrices de contrôle qui dirigent son expression ; et une seconde cassette d'expression qui comprend un deuxième orf, un lieur, et un troisième orf sous le contrôle de séquences régulatrices de contrôle qui dirigent son expression, le deuxième et le troisième orf codant pour une deuxième et une troisième construction d'immunoglobuline. Dans un mode de réalisation, le vecteur exprimant conjointement ces deux constructions d'anticorps est un aav, dans lequel les séquences répétées inversées terminales en 5' et 3' encadrent les cassettes d'expression et les séquences régulatrices.
Patent MA-46139-A1 (MA)
Title: Systèmes et procédés de commutation d'oscillateurs à quartz de référence pour un émetteur-récepteur d'un dispositif sans fil
Inventor: LINDOFF BENGT
IPC: H04B1/00
Filed: 2016-12-19
Abstract: L'invention concerne des systèmes et des procédés qui se rapportent à un dispositif sans fil qui utilise de manière intelligente différents oscillateurs à quartz (xo) de référence pour une ou des boucles à verrouillage de phase (pll) dans un émetteur-récepteur du dispositif sans fil. Des modes de réalisation d'un procédé de fonctionnement d'un dispositif sans fil comprennent un premier xo qui fonctionne à une première fréquence de référence et un second xo qui fonctionne à une seconde fréquence de référence qui est supérieure à la première fréquence de référence. Dans certains modes de réalisation, le procédé de fonctionnement des dispositifs sans fil consiste à prendre une décision quant à savoir s'il faut configurer un récepteur du dispositif sans fil de façon à utiliser le premier xo ou le second xo, et à configurer le récepteur du dispositif sans fil de façon à utiliser le premier xo ou le second xo en fonction de la décision.